hMLH1 and hMSH2 mutations in families with familial clustering of gastric cancer and hereditary non-polyposis colorectal cancer - PubMed (original) (raw)

Affiliations

PMID: 12132870

hMLH1 and hMSH2 mutations in families with familial clustering of gastric cancer and hereditary non-polyposis colorectal cancer

J C Kim et al. Cancer Detect Prev. 2001.

Abstract

The pattern of hMLHI and hMSH2 mutations was assessed to identify the genetic correlation between hereditary gastric and colorectal cancers. Four disease groups and their healthy family members were assembled according to the presentation of gastric cancer: FG, familial clustering of gastric cancer (n = 32); CG, family with one or more colorectal and gastric cancers in first-degree relatives (n = 22); HS, seven HNPCC families corresponding to the Amsterdam criteria (AMS+) and 12 suspected HNPCC families which did not satisfy one of the criteria (AMS-), but no gastric cancer among first- and second-degree relatives (n = 19); and SG, sporadic gastric cancer (n = 33). In the CG group, three were included in AMS + and six in AMS- criteria. Peripheral blood was obtained from them to detect hMLHI and hMLH2 mutations using PCR-SSCP analysis and direct sequencing. The incidence of mutations was 9.4% in the FG group, 54.5% in the CG group, 31.6% in the HS group, and none in the SG group. The incidence, type, and number of the mutation were not different between the CG and HS groups. Thirty-four different mutations included 19 in hMLH1 and 15 in hMSH2. Gastric cancer was the most common extracolonic malignancy in HNPCC and suspected HNPCC families (9/28, 32.1%). The hMLH1 or hMSH2 mutation occurred in seven of 10 families with AMS+, whereas it occurred in four of 18 with AMS- (70% vs. 22.2%, P = .013). Five mutations in the hMLH1 and six mutations in the hMSH2 were exclusively found in families with gastric cancer. All three mutations in the FG group were in hMLHI and there was no mutation in their healthy family members. This study demonstrates that some familial clustering type of gastric cancer appears to be associated with hMLHI mutations thereby indicating a difference from the hereditary gastric cancer studies previously reported. In addition, hMLHI and hMSH2 mutations may impact the gastric cancer carcinogenesis in HNPCC or suspected HNPCC.

PubMed Disclaimer

Cited by

Frequency of extracolonic tumors in Brazilian families with Lynch syndrome: analysis of a hereditary colorectal cancer institutional registry.
da Silva FC, de Oliveira LP, Santos EM, Nakagawa WT, Aguiar Junior S, Valentin MD, Rossi BM, de Oliveira Ferreira F. da Silva FC, et al. Fam Cancer. 2010 Dec;9(4):563-70. doi: 10.1007/s10689-010-9373-2. Fam Cancer. 2010. PMID: 20697958
Missense mutations of MLH1 and MSH2 genes detected in patients with gastrointestinal cancer are associated with exonic splicing enhancers and silencers.
Zhu M, Chen HM, Wang YP. Zhu M, et al. Oncol Lett. 2013 May;5(5):1710-1718. doi: 10.3892/ol.2013.1243. Epub 2013 Mar 11. Oncol Lett. 2013. PMID: 23760103 Free PMC article.
Colon cancer associated genes exhibit signatures of positive selection at functionally significant positions.
Morgan CC, Shakya K, Webb A, Walsh TA, Lynch M, Loscher CE, Ruskin HJ, O'Connell MJ. Morgan CC, et al. BMC Evol Biol. 2012 Jul 12;12:114. doi: 10.1186/1471-2148-12-114. BMC Evol Biol. 2012. PMID: 22788692 Free PMC article.
Association between pepsinogen C gene polymorphism and genetic predisposition to gastric cancer.
Liu HJ, Guo XL, Dong M, Wang L, Yuan Y. Liu HJ, et al. World J Gastroenterol. 2003 Jan;9(1):50-3. doi: 10.3748/wjg.v9.i1.50. World J Gastroenterol. 2003. PMID: 12508350 Free PMC article.
Surveillance in Lynch syndrome.
Mecklin JP, Järvinen HJ. Mecklin JP, et al. Fam Cancer. 2005;4(3):267-71. doi: 10.1007/s10689-005-1475-x. Fam Cancer. 2005. PMID: 16136388 Review.

hMLH1 and hMSH2 mutations in families with familial clustering of gastric cancer and hereditary non-polyposis colorectal cancer - PubMed (original) (raw)